Ultracaine® is the world’s original articaine and one of HANSAmed’s key products. It is available as an injectable local anesthetic and has been sold exclusively in Canada through HANSAmed since 1999.
Ultracaine D-S contains 4% articaine hydrochloride (40 mg/mL) with 1:200,000 epinephrine (0.006 mg/mL epinephrine hydrochloride, which corresponds to 0.005 mg/mL epinephrine as a free base), sodium metabisulphite (0.50 mg/mL) as antioxidant, and water for injection.
Ultracaine® D-S Regular: 4% articaine HCl injection
- 1:200,000 straight epinephrine
- Provides 45-60 minutes of safe and effective pulpal anesthesia
Soft Tissue Anesthesia:
- Provides 120-300 minutes of safe and effective soft tissue anesthesia
- 2-3 minutes onset
- 27 minutes half-life
Indications & Clinical Use
Ultracaine D-S (articaine with epinephrine) solutions for injection are indicated for infiltration anesthesia and nerve block anesthesia in clinical dentistry.
Geriatrics (>65 years of age): elderly patients should be given reduced doses commensurate with their age and physical condition.
Pediatrics (<4 years of age): the use of Ultracaine D-S and Ultracaine D-S Forte (articaine with epinephrine solutions) in children under the age of 4 years is not recommended.